MOLINA HEALTHCARE INC (MOH) Stock Fundamental Analysis

NYSE:MOH • US60855R1005

152.42 USD
-1.63 (-1.06%)
At close: Mar 2, 2026
152.42 USD
0 (0%)
After Hours: 3/2/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, MOH scores 5 out of 10 in our fundamental rating. MOH was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of MOH get a neutral evaluation. Nothing too spectacular is happening here. MOH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • MOH had positive earnings in the past year.
  • MOH had a negative operating cash flow in the past year.
  • Each year in the past 5 years MOH has been profitable.
  • Of the past 5 years MOH 4 years had a positive operating cash flow.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • The Return On Assets of MOH (3.03%) is better than 64.36% of its industry peers.
  • With a decent Return On Equity value of 11.60%, MOH is doing good in the industry, outperforming 76.24% of the companies in the same industry.
  • MOH's Return On Invested Capital of 7.39% is fine compared to the rest of the industry. MOH outperforms 68.32% of its industry peers.
  • MOH had an Average Return On Invested Capital over the past 3 years of 14.32%. This is significantly above the industry average of 9.12%.
  • The 3 year average ROIC (14.32%) for MOH is well above the current ROIC(7.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROIC 7.39%
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.04%, MOH is in line with its industry, outperforming 56.44% of the companies in the same industry.
  • In the last couple of years the Profit Margin of MOH has declined.
  • The Operating Margin of MOH (1.73%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of MOH has declined.
  • MOH has a Gross Margin of 13.07%. This is in the lower half of the industry: MOH underperforms 67.33% of its industry peers.
  • In the last couple of years the Gross Margin of MOH has declined.
Industry RankSector Rank
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
  • Compared to 1 year ago, MOH has less shares outstanding
  • The number of shares outstanding for MOH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, MOH has a worse debt to assets ratio.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • MOH has an Altman-Z score of 4.21. This indicates that MOH is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.21, MOH is doing good in the industry, outperforming 77.23% of the companies in the same industry.
  • MOH has a Debt/Equity ratio of 0.97. This is a neutral value indicating MOH is somewhat dependend on debt financing.
  • MOH has a Debt to Equity ratio of 0.97. This is comparable to the rest of the industry: MOH outperforms 41.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 4.21
ROIC/WACC0.95
WACC7.75%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • MOH has a Current Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.69, MOH is in the better half of the industry, outperforming 66.34% of the companies in the same industry.
  • MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
  • MOH's Quick ratio of 1.69 is fine compared to the rest of the industry. MOH outperforms 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The earnings per share for MOH have decreased strongly by -52.98% in the last year.
  • MOH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.02% yearly.
  • MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.75%.
  • MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.52% yearly.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%

3.2 Future

  • MOH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.69% yearly.
  • Based on estimates for the next years, MOH will show a small growth in Revenue. The Revenue will grow by 4.17% on average per year.
EPS Next Y30.54%
EPS Next 2Y23.84%
EPS Next 3Y32.83%
EPS Next 5Y21.69%
Revenue Next Year0.69%
Revenue Next 2Y3.49%
Revenue Next 3Y3.9%
Revenue Next 5Y4.17%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.31, the valuation of MOH can be described as correct.
  • Based on the Price/Earnings ratio, MOH is valued cheaper than 83.17% of the companies in the same industry.
  • MOH is valuated rather cheaply when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
  • MOH is valuated reasonably with a Price/Forward Earnings ratio of 10.96.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 88.12% of the companies listed in the same industry.
  • MOH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.11.
Industry RankSector Rank
PE 14.31
Fwd PE 10.96
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.47
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • MOH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as MOH's earnings are expected to grow with 32.83% in the coming years.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y23.84%
EPS Next 3Y32.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • MOH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOLINA HEALTHCARE INC

NYSE:MOH (3/2/2026, 8:04:00 PM)

After market: 152.42 0 (0%)

152.42

-1.63 (-1.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-21
Inst Owners113.06%
Inst Owner Change-8.03%
Ins Owners1.33%
Ins Owner Change0.2%
Market Cap7.77B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts56.3
Price Target156.67 (2.79%)
Short Float %5.75%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-10.78%
PT rev (3m)-11.32%
EPS NQ rev (1m)-38.22%
EPS NQ rev (3m)-35.72%
EPS NY rev (1m)-0.42%
EPS NY rev (3m)-5.08%
Revenue NQ rev (1m)-5.1%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-3.56%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 14.31
Fwd PE 10.96
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 1.91
P/tB 4.15
EV/EBITDA -0.47
EPS(TTM)10.65
EY6.99%
EPS(NY)13.9
Fwd EY9.12%
FCF(TTM)-12.47
FCFYN/A
OCF(TTM)-10.49
OCFYN/A
SpS890.71
BVpS79.78
TBVpS36.75
PEG (NY)0.47
PEG (5Y)N/A
Graham Number138.27
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROCE 9.57%
ROIC 7.39%
ROICexc N/A
ROICexgc N/A
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
FCFM N/A
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 51.79%
Cap/Sales 0.22%
Interest Coverage 4.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 4.21
F-Score4
WACC7.75%
ROIC/WACC0.95
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y30.54%
EPS Next 2Y23.84%
EPS Next 3Y32.83%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0.69%
Revenue Next 2Y3.49%
Revenue Next 3Y3.9%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A

MOLINA HEALTHCARE INC / MOH FAQ

Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 5 / 10 to MOH.


What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?

ChartMill assigns a valuation rating of 6 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Fairly Valued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MOH stock?

The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 14.31 and the Price/Book (PB) ratio is 1.91.